Incredibly, whenever a study site reported a clinical event, GSK and its contract research organization (CRO), knew immediately which drug the patient was receiving.
In a widely cited study, Mr Castelar found that, presented with a choice between upholding a contract and promoting social justice, three-quarters of judges would choose the latter.